Company: NDRA
Filing Date: 2025-07-16
Form Type: S-1/A
Source: 0001654954-25-008117
Chunk: 58

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-16
Form: S-1/A
Chunk 58
---
other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |

| 42 |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Ann Arbor, State of Michigan, on the day of July 16, 2025.

| ENDRA Life Sciences Inc. |                         |
| By:                      | /s/ Alexander Tokman    |
| Name:                    | Alexander Tokman        |
| Title:                   | Chief Executive Officer |

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

| Signatures             
 /s/ Alexander Tokman   |     | Title                                                                           
 Chief Executive Officer and Chairman of the Board (Principal Executive Officer) |     | Date          
 July 16, 2025 |
|:-----------------------|:----|:--------------------------------------------------------------------------------|:----|:--------------|
| Alexander Tokman       |     |                                                                                 |     |               |
| /s/ Richard Jacroux    |     | Chief Financial Officer (Principal Financial and Accounting Officer)            |     | July 16, 2025 |
| Richard Jacroux        |     |                                                                                 |     |               |
| *                      |     | Director                                                                        |     | July 16, 2025 |
| Louis J. Basenese      |     |                                                                                 |     |               |
| *                      |     | Director                                                                        |     | July 16, 2025 |
| Anthony DiGiandomenico |     |                                                                                 |     |               |
| *                      |     | Director                                                                        |     | July 16, 2025 |
| Michael Harsh          |     |                                                                                 |     |               |

| *By: | /s/ Alexander Tok